English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Department of Medicine, Division of Hematology, Lillebælt Hospital, Vejle, Denmark; Department of Regional Health Research (IRS) at the University of Southern Denmark (SDU), Odense, Denmark Department of Hematology, Aarhus University Hospital, Aarhus, Denmark Department of Radiology, Lillebælt Hospital, Vejle, Denmark Department of Nuclear Medicine, Lillebælt Hospital, Vejle, Denmark Department of Clinical Immunology and Biochemistry, Lillebælt Hospital, Vejle, Denmark Department of Clinical Genetics, Lillebælt Hospital, Vejle, Denmark

clinical hematology international

Safety and Efficacy of Doxorubicin, Cyclophosphamide, Bortezomib, Dexamethasone and Lenalidomide Followed by Bortezomib Consolidation as First-Line Therapy in Patients with Newly Diagnosed Multiple Myeloma